0001209191-17-031930.txt : 20170512
0001209191-17-031930.hdr.sgml : 20170512
20170512161732
ACCESSION NUMBER: 0001209191-17-031930
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170510
FILED AS OF DATE: 20170512
DATE AS OF CHANGE: 20170512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nicholson Garry A
CENTRAL INDEX KEY: 0001640861
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 17838865
MAIL ADDRESS:
STREET 1: C/O TESARO, INC.
STREET 2: 1000 WINTER STREET, SUITE 3300
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-10
0
0001175505
FIVE PRIME THERAPEUTICS INC
FPRX
0001640861
Nicholson Garry A
TWO CORPORATE DRIVE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (right to buy)
29.80
2017-05-10
4
A
0
15000
0.00
A
2027-05-09
Common Stock
15000
15000
D
The shares underlying this option vest at a rate of one-third per year on each anniversary of May 10, 2017, subject to the reporting person's continued service to Five Prime Therapeutics, Inc. through each such date.
/s/ Francis Sarena, Attorney-in-fact
2017-05-12